Skip to content

Medpace Voice

Tag: Infectious Diseases and Vaccines

Clinical Development

A New Paradigm in Infectious Diseases Treatment & Prophylaxis Shaped by the Current Pandemic

  • June 2, 2021

The COVID-19 pandemic will end, or as any pandemic in the past, will lose its momentum. Yet, the precedents and the new paradigms formed in…

Clinical Development

Webinar: Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID-19 Pandemic

  • April 21, 2021

Join AMR experts from Medpace, IHMA, and GARDP as they discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize…

Clinical Development

Infectious Diseases in the Immunocompromised Host

  • February 3, 2020

An in-depth look at infectious diseases including hematologic malignancies in immunocompromised patients and the unique challenges for clinical development.

Company Spotlight

Medpace Bolsters Medical Leadership in Infectious Diseases and Asia-Pac Region

  • December 6, 2019

Medpace (MEDP) a scientifically-driven, global, full-service clinical contract research organization (CRO) known for its strong scientific expertise, announced the addition...

Clinical Development

Decreasing Timelines in Infectious Diseases Drug Development

  • November 29, 2018

Nothing derails a clinical study timeline more than poor planning and not anticipating and preparing for potential roadblocks. While you may not be able to…

Clinical Development

The Potential Power of the Human Microbiome for Drug Development

  • February 6, 2018

The dynamic nature of the microbiome is driving momentum and enthusiasm for clinical research. Recent advances in analyzing the microbiome and how it impacts immunity…

Clinical Development

New Whitepaper: The Microbiome in Clinical Trials – Opportunities and Challenges

  • November 30, 2017

Medpace and Diversigen discuss the opportunities and challenges of the microbiome in clinical trials in a recently published whitepaper. You can access the whitepaper in…

Clinical Development

Q&A with Dr. Brian Murphy, VP of Medical Affairs for Infectious Diseases

  • July 24, 2017

In this post, Dr. Brian Murphy, Vice President of Medical Affairs for Infectious Diseases, discusses the following topic: “Source Control Review in Clinical Trials of…

Clinical Development

The Promising Landscape of Microbiome-based Clinical Research

  • May 20, 2017

Recent discoveries have been made that have revealed the power of microbes to prevent, diagnose, and treat disease. As a result of these discoveries, clinical…

Central Laboratories

Medpace and IHMA Announce Strategic Alliance to Provide Microbiology Laboratory Services for Clinical Studies

  • June 13, 2016

Medpace, a global full service Contract Research Organization (CRO) and International Health Management Associates, Inc. (IHMA), a full service central...